Last 12 months
Inside the activity.
0 purchase rows · 36 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 30 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 30, 2021 Filed Aug 31, 2021 21:01 UTC |
Turner Kathy VSenior Vice President
|
Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 2,250 | Not disclosed Strike: $79.54 | Not disclosed |
DisclosureSEC source: 0001567619-21-016516 · doc1.xml · derivative · entry 8 Turner Kathy V · CIK 0001740719 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,736 Underlying: Common Stock · 2,250 shares Expires 2025-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Not applicable. F4 · derivative.exercise_date: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,993 shares in five annual installments beginning February 15, 2016, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:01 UTC |
Turner Kathy VSenior Vice President
|
SaleCommon Stock | 1,250 | $689.00 | $861,250.00 |
DisclosureSEC source: 0001567619-21-016516 · doc1.xml · nonDerivative · entry 5 Turner Kathy V · CIK 0001740719 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,875.3869 Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:01 UTC |
Turner Kathy VSenior Vice President
|
SaleCommon Stock | 1,000 | $685.00 | $685,000.00 |
DisclosureSEC source: 0001567619-21-016516 · doc1.xml · nonDerivative · entry 4 Turner Kathy V · CIK 0001740719 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,125.3869 Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:01 UTC |
Turner Kathy VSenior Vice President
|
Exercise / conversionCommon Stock | 2,250 | $79.54 | $178,965.00 |
DisclosureSEC source: 0001567619-21-016516 · doc1.xml · nonDerivative · entry 3 Turner Kathy V · CIK 0001740719 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,125.3869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 21:01 UTC |
Turner Kathy VSenior Vice President
|
Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 276 | Not disclosed Strike: $64.24 | Not disclosed |
DisclosureSEC source: 0001567619-21-016516 · doc1.xml · derivative · entry 7 Turner Kathy V · CIK 0001740719 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 276 shares Expires 2024-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Not applicable. F3 · derivative.exercise_date: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 138 shares in five annual installments beginning June 1, 2015, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 21:01 UTC |
Turner Kathy VSenior Vice President
|
SaleCommon Stock | 276 | $678.00 | $187,128.00 |
DisclosureSEC source: 0001567619-21-016516 · doc1.xml · nonDerivative · entry 2 Turner Kathy V · CIK 0001740719 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,875.3869 Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 21:01 UTC |
Turner Kathy VSenior Vice President
|
Exercise / conversionCommon Stock | 276 | $64.24 | $17,730.24 |
DisclosureSEC source: 0001567619-21-016516 · doc1.xml · nonDerivative · entry 1 Turner Kathy V · CIK 0001740719 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,151.3869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes a total of 9.3869 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2021. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 21:00 UTC |
POLEWACZYK JAMES FExecutive Vice President
|
GiftCommon Stock | 522 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-016332 · doc1.xml · nonDerivative · entry 1 POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,494.2845 F1 · balance_after: Includes 11.2845 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2021. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 21:02 UTC |
MAZELSKY JONATHAN JAYDirector · President & CEO
|
SaleCommon Stock | 60 | $675.44 | $40,526.10 |
DisclosureSEC source: 0001567619-21-016001 · doc1.xml · nonDerivative · entry 7 MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,426.6426 F7 · price: Represents the weighted average price of the shares sold ranging from a low of $675.29 to a high of $675.47 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 21:02 UTC |
MAZELSKY JONATHAN JAYDirector · President & CEO
|
SaleCommon Stock | 182 | $674.48 | $122,755.71 |
DisclosureSEC source: 0001567619-21-016001 · doc1.xml · nonDerivative · entry 6 MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,486.6426 F6 · price: Represents the weighted average price of the shares sold ranging from a low of $674.16 to a high of $674.91 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 21:02 UTC |
MAZELSKY JONATHAN JAYDirector · President & CEO
|
SaleCommon Stock | 488 | $673.69 | $328,760.92 |
DisclosureSEC source: 0001567619-21-016001 · doc1.xml · nonDerivative · entry 5 MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,668.6426 F5 · price: Represents the weighted average price of the shares sold ranging from a low of $673.13 to a high of $674.07 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 21:02 UTC |
MAZELSKY JONATHAN JAYDirector · President & CEO
|
SaleCommon Stock | 533 | $672.36 | $358,367.88 |
DisclosureSEC source: 0001567619-21-016001 · doc1.xml · nonDerivative · entry 4 MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,156.6426 F4 · price: Represents the weighted average price of the shares sold ranging from a low of $672.08 to a high of $673.02 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 21:02 UTC |
MAZELSKY JONATHAN JAYDirector · President & CEO
|
SaleCommon Stock | 337 | $677.58 | $228,343.04 |
DisclosureSEC source: 0001567619-21-016001 · doc1.xml · nonDerivative · entry 3 MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,689.6426 F3 · price: Represents the weighted average price of the shares sold ranging from a low of $677.13 to a high of $677.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 21:02 UTC |
MAZELSKY JONATHAN JAYDirector · President & CEO
|
SaleCommon Stock | 983 | $676.38 | $664,886.06 |
DisclosureSEC source: 0001567619-21-016001 · doc1.xml · nonDerivative · entry 2 MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,026.6426 F2 · price: Represents the weighted average price of the shares sold ranging from a low of $676.01 to a high of $676.99 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 21:02 UTC |
MAZELSKY JONATHAN JAYDirector · President & CEO
|
SaleCommon Stock | 3,417 | $675.34 | $2,307,622.77 |
DisclosureSEC source: 0001567619-21-016001 · doc1.xml · nonDerivative · entry 1 MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,009.6426 F1 · price: Represents the weighted average price of the shares sold ranging from a low of $675.00 to a high of $675.89 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 21:01 UTC |
JUNIUS DANIEL MDirector
|
Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 2,402 | Not disclosed Strike: $85.00 | Not disclosed |
DisclosureSEC source: 0001567619-21-015281 · doc1.xml · derivative · entry 3 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,402 shares Expires 2026-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable. F2 · derivative.exercise_date: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2017 annual meeting of shareholders. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 21:01 UTC |
JUNIUS DANIEL MDirector
|
SaleCommon Stock | 2,402 | $679.58 | $1,632,355.48 |
DisclosureSEC source: 0001567619-21-015281 · doc1.xml · nonDerivative · entry 2 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,896 F1 · price: Represents the weighted average price of the shares sold ranging from a low of $679.47 to a high of $680.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 21:01 UTC |
JUNIUS DANIEL MDirector
|
Exercise / conversionCommon Stock | 2,402 | $85.00 | $204,170.00 |
DisclosureSEC source: 0001567619-21-015281 · doc1.xml · nonDerivative · entry 1 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 21:00 UTC |
Hunt NimrataExecutive Vice President
|
Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative | 337 | Not disclosed Strike: $141.60 | Not disclosed |
DisclosureSEC source: 0001567619-21-015280 · doc1.xml · derivative · entry 4 Hunt Nimrata · CIK 0001800619 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 706 Underlying: Common Stock · 337 shares Expires 2027-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable. F2 · derivative.exercise_date: Grant of option to buy 1,043 shares of Issuer common stock that vested as to 337 shares on February 14, 2021 and vests as to the remainder on February 14, 2022. F2 · ownership.direct: Grant of option to buy 1,043 shares of Issuer common stock that vested as to 337 shares on February 14, 2021 and vests as to the remainder on February 14, 2022. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 21:00 UTC |
Hunt NimrataExecutive Vice President
|
Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative | 769 | Not disclosed Strike: $67.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-015280 · doc1.xml · derivative · entry 3 Hunt Nimrata · CIK 0001800619 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 769 shares Expires 2026-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not applicable. F1 · derivative.exercise_date: Grant of option to buy 1,906 shares of Issuer common stock that vested as to 30 shares on February 14, 2018, 365 shares on February 14, 2020, and as to the remainder on February 14, 2021. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 21:00 UTC |
Hunt NimrataExecutive Vice President
|
Exercise / conversionCommon Stock | 337 | $141.60 | $47,719.20 |
DisclosureSEC source: 0001567619-21-015280 · doc1.xml · nonDerivative · entry 2 Hunt Nimrata · CIK 0001800619 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,212.2845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 21:00 UTC |
Hunt NimrataExecutive Vice President
|
Exercise / conversionCommon Stock | 769 | $67.85 | $52,176.65 |
DisclosureSEC source: 0001567619-21-015280 · doc1.xml · nonDerivative · entry 1 Hunt Nimrata · CIK 0001800619 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,875.2845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:02 UTC |
SZOSTAK M ANNEDirector
|
SaleCommon Stock | 5 | $694.62 | $3,473.10 |
DisclosureSEC source: 0001567619-21-014772 · doc1.xml · nonDerivative · entry 10 SZOSTAK M ANNE · CIK 0001094176 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · 2021 Szostak IDEXX GRAT Disclosed balance after: 7,217 Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:02 UTC |
SZOSTAK M ANNEDirector
|
SaleCommon Stock | 595 | $693.91 | $412,875.44 |
DisclosureSEC source: 0001567619-21-014772 · doc1.xml · nonDerivative · entry 9 SZOSTAK M ANNE · CIK 0001094176 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · 2021 Szostak IDEXX GRAT Disclosed balance after: 7,222 F10 · price: Represents the weighted average price of the shares sold ranging from a low of $693.53 to a high of $694.51 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:02 UTC |
SZOSTAK M ANNEDirector
|
SaleCommon Stock | 300 | $691.75 | $207,523.65 |
DisclosureSEC source: 0001567619-21-014772 · doc1.xml · nonDerivative · entry 8 SZOSTAK M ANNE · CIK 0001094176 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · 2021 Szostak IDEXX GRAT Disclosed balance after: 7,817 F9 · price: Represents the weighted average price of the shares sold ranging from a low of $691.47 to a high of $692.22 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:02 UTC |
SZOSTAK M ANNEDirector
|
SaleCommon Stock | 300 | $690.65 | $207,194.70 |
DisclosureSEC source: 0001567619-21-014772 · doc1.xml · nonDerivative · entry 7 SZOSTAK M ANNE · CIK 0001094176 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · 2021 Szostak IDEXX GRAT Disclosed balance after: 8,117 F8 · price: Represents the weighted average price of the shares sold ranging from a low of $690.32 to a high of $691.21 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:02 UTC |
SZOSTAK M ANNEDirector
|
SaleCommon Stock | 300 | $689.60 | $206,881.20 |
DisclosureSEC source: 0001567619-21-014772 · doc1.xml · nonDerivative · entry 6 SZOSTAK M ANNE · CIK 0001094176 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · 2021 Szostak IDEXX GRAT Disclosed balance after: 8,417 F7 · price: Represents the weighted average price of the shares sold ranging from a low of $689.27 to a high of $690.23 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:02 UTC |
SZOSTAK M ANNEDirector
|
SaleCommon Stock | 261 | $685.98 | $179,041.93 |
DisclosureSEC source: 0001567619-21-014772 · doc1.xml · nonDerivative · entry 5 SZOSTAK M ANNE · CIK 0001094176 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · 2021 Szostak IDEXX GRAT Disclosed balance after: 8,717 F6 · price: Represents the weighted average price of the shares sold ranging from a low of $685.48 to a high of $686.35 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:02 UTC |
SZOSTAK M ANNEDirector
|
SaleCommon Stock | 439 | $684.96 | $300,696.39 |
DisclosureSEC source: 0001567619-21-014772 · doc1.xml · nonDerivative · entry 4 SZOSTAK M ANNE · CIK 0001094176 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · 2021 Szostak IDEXX GRAT Disclosed balance after: 8,978 F5 · price: Represents the weighted average price of the shares sold ranging from a low of $684.39 to a high of $685.25 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:02 UTC |
SZOSTAK M ANNEDirector
|
SaleCommon Stock | 120 | $683.71 | $82,045.00 |
DisclosureSEC source: 0001567619-21-014772 · doc1.xml · nonDerivative · entry 3 SZOSTAK M ANNE · CIK 0001094176 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · 2021 Szostak IDEXX GRAT Disclosed balance after: 9,417 F4 · price: Represents the weighted average price of the shares sold ranging from a low of $683.38 to a high of $683.79 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:02 UTC |
SZOSTAK M ANNEDirector
|
SaleCommon Stock | 368 | $682.77 | $251,259.51 |
DisclosureSEC source: 0001567619-21-014772 · doc1.xml · nonDerivative · entry 2 SZOSTAK M ANNE · CIK 0001094176 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · 2021 Szostak IDEXX GRAT Disclosed balance after: 9,537 F3 · price: Represents the weighted average price of the shares sold ranging from a low of $682.30 to a high of $683.20 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:02 UTC |
SZOSTAK M ANNEDirector
|
SaleCommon Stock | 312 | $681.49 | $212,624.94 |
DisclosureSEC source: 0001567619-21-014772 · doc1.xml · nonDerivative · entry 1 SZOSTAK M ANNE · CIK 0001094176 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · 2021 Szostak IDEXX GRAT Disclosed balance after: 9,905 F2 · price: Represents the weighted average price of the shares sold ranging from a low of $681.18 to a high of $682.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. F1 · ownership.nature: The reporting person is the settlor and trustee of the 2021 Szostak IDEXX GRAT (the "GRAT"). The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 21:01 UTC |
MCKEON BRIAN PExecutive VP & CFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-014771 · doc1.xml · derivative · entry 4 MCKEON BRIAN P · CIK 0001219445 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,658 Underlying: Common Stock · 192 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020. F3 · price: Not applicable. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020. F2 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 21:01 UTC |
MCKEON BRIAN PExecutive VP & CFO
|
Tax withholdingCommon Stock | 96 | $705.76 | $67,752.96 |
DisclosureSEC source: 0001567619-21-014771 · doc1.xml · nonDerivative · entry 2 MCKEON BRIAN P · CIK 0001219445 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,307.6426 Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 21:01 UTC |
MCKEON BRIAN PExecutive VP & CFO
|
Exercise / conversionCommon Stock | 192 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-014771 · doc1.xml · nonDerivative · entry 1 MCKEON BRIAN P · CIK 0001219445 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,403.6426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes a total of 23.6426 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 21:01 UTC |
MAZELSKY JONATHAN JAYDirector · President & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 385 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-014769 · doc1.xml · derivative · entry 3 MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,605 Underlying: Common Stock · 385 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020. F3 · price: Not applicable. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020. F2 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning August 5, 2020. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 21:01 UTC |
MAZELSKY JONATHAN JAYDirector · President & CEO
|
Tax withholdingCommon Stock | 179 | $705.76 | $126,331.04 |
DisclosureSEC source: 0001567619-21-014769 · doc1.xml · nonDerivative · entry 2 MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,426.6426 Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 21:01 UTC |
MAZELSKY JONATHAN JAYDirector · President & CEO
|
Exercise / conversionCommon Stock | 385 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-014769 · doc1.xml · nonDerivative · entry 1 MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,605.6426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 11.6426 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2021. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 21:00 UTC |
Hunt NimrataExecutive Vice President
|
Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 511 | Not disclosed Strike: $141.60 | Not disclosed |
DisclosureSEC source: 0001567619-21-014768 · doc1.xml · derivative · entry 6 Hunt Nimrata · CIK 0001800619 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,218 Underlying: Common Stock · 511 shares Expires 2027-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Not applicable. F3 · derivative.exercise_date: Grant of option to buy 3,579 shares of Issuer common stock that vest in five annual installments beginning on February 14, 2018. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 21:00 UTC |
Hunt NimrataExecutive Vice President
|
Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 27 | Not disclosed Strike: $67.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-014768 · doc1.xml · derivative · entry 5 Hunt Nimrata · CIK 0001800619 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27 shares Expires 2026-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Not applicable. F2 · derivative.exercise_date: Grant of option to buy 1,940 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2017. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 21:00 UTC |
Hunt NimrataExecutive Vice President
|
SaleCommon Stock | 538 | $703.00 | $378,214.00 |
DisclosureSEC source: 0001567619-21-014768 · doc1.xml · nonDerivative · entry 3 Hunt Nimrata · CIK 0001800619 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,106.2845 Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 21:00 UTC |
Hunt NimrataExecutive Vice President
|
Exercise / conversionCommon Stock | 511 | $141.60 | $72,357.60 |
DisclosureSEC source: 0001567619-21-014768 · doc1.xml · nonDerivative · entry 2 Hunt Nimrata · CIK 0001800619 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,644.2845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 21:00 UTC |
Hunt NimrataExecutive Vice President
|
Exercise / conversionCommon Stock | 27 | $67.85 | $1,831.95 |
DisclosureSEC source: 0001567619-21-014768 · doc1.xml · nonDerivative · entry 1 Hunt Nimrata · CIK 0001800619 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,133.2845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes a total of 23.2845 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 21:02 UTC |
TWIGGE GIOVANISenior Vice President
|
Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 1,893 | Not disclosed Strike: $288.78 | Not disclosed |
DisclosureSEC source: 0001567619-21-014513 · doc1.xml · derivative · entry 15 TWIGGE GIOVANI · CIK 0001500399 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,677 Underlying: Common Stock · 1,893 shares Expires 2030-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · price: Not applicable. F10 · derivative.exercise_date: Grant of option to buy 7,570 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 21:02 UTC |
TWIGGE GIOVANISenior Vice President
|
Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 3,068 | Not disclosed Strike: $206.94 | Not disclosed |
DisclosureSEC source: 0001567619-21-014513 · doc1.xml · derivative · entry 14 TWIGGE GIOVANI · CIK 0001500399 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,118 Underlying: Common Stock · 3,068 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · price: Not applicable. F9 · derivative.exercise_date: Grant of option to buy 7,186 shares of Issuer common stock that vest in four annual installments beginning February 14, 2020. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 21:02 UTC |
TWIGGE GIOVANISenior Vice President
|
Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 5,141 | Not disclosed Strike: $178.26 | Not disclosed |
DisclosureSEC source: 0001567619-21-014513 · doc1.xml · derivative · entry 13 TWIGGE GIOVANI · CIK 0001500399 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,866 Underlying: Common Stock · 5,141 shares Expires 2028-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · price: Not applicable. F8 · derivative.exercise_date: Grant of option to buy 8,007 shares of Issuer common stock that vest in five annual installments beginning February 14, 2019. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 21:02 UTC |
TWIGGE GIOVANISenior Vice President
|
SaleCommon Stock | 860 | $701.36 | $603,170.29 |
DisclosureSEC source: 0001567619-21-014513 · doc1.xml · nonDerivative · entry 10 TWIGGE GIOVANI · CIK 0001500399 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,128.478 F5 · price: Represents the weighted average price of the shares sold ranging from a low of $701.05 to a high of $701.91 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 21:02 UTC |
TWIGGE GIOVANISenior Vice President
|
SaleCommon Stock | 9,242 | $700.30 | $6,472,197.55 |
DisclosureSEC source: 0001567619-21-014513 · doc1.xml · nonDerivative · entry 9 TWIGGE GIOVANI · CIK 0001500399 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,988.478 F4 · price: Represents the weighted average price of the shares sold ranging from a low of $700.00 to a high of $700.995 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 21:02 UTC |
TWIGGE GIOVANISenior Vice President
|
SaleCommon Stock | 1,319 | $700.00 | $923,300.00 |
DisclosureSEC source: 0001567619-21-014513 · doc1.xml · nonDerivative · entry 8 TWIGGE GIOVANI · CIK 0001500399 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,230.478 Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 21:02 UTC |
TWIGGE GIOVANISenior Vice President
|
Exercise / conversionCommon Stock | 1,893 | $288.78 | $546,660.54 |
DisclosureSEC source: 0001567619-21-014513 · doc1.xml · nonDerivative · entry 7 TWIGGE GIOVANI · CIK 0001500399 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,549.478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.